The Recall Desk

Manufacturer

Jubilant Cadista Pharmaceuticals, Inc.

31 recalls in our database name Jubilant Cadista Pharmaceuticals, Inc. as the manufacturing or recalling firm.

What the numbers show

Total
31
Critical
0
Severe
4
Most recent
2023-01-11

Of the 31 recalls from Jubilant Cadista Pharmaceuticals, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 4 (13%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

26–31 of 31

  • ModerateFDA (Drugs)·D-0670-2017·2017-04-19

    Jubilant Cadista Recalls Bupropion Hydrochloride Tablets Due to Impurities

    Jubilant Cadista Pharmaceuticals is recalling Bupropion Hydrochloride Extended-release Tablets because they failed impurity specifications.

    Product
    BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, packaged in a) 60-count bottles (NDC 59746-316-60) and b) 100-count bottles (NDC 59746-316-01), Rx only, Manufactured by: Julibant Life Sciences Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmace
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0669-2017·2017-04-19

    Jubilant Cadista Recalls Bupropion Hydrochloride Tablets for Impurity Issues

    Jubilant Cadista Pharmaceuticals is recalling specific lots of Bupropion Hydrochloride Extended-release Tablets due to high levels of a degradation product.

    Product
    BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 100 mg, packaged in a) 60-count bottles (NDC 59746-315-60) and b) 100-count bottles (NDC 59746-315-01), Rx only, Manufactured by: Julibant Life Sciences Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmace
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0671-2017·2017-04-19

    Jubilant Cadista Recalls Bupropion Hydrochloride Tablets for Impurity Failure

    Jubilant Cadista Pharmaceuticals is recalling Bupropion Hydrochloride Extended-release Tablets because high levels of a degradation product were detected.

    Product
    BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, packaged in a) 60-count bottles (NDC 59746-317-60) and b) 100-count bottles (NDC 59746-317-01), Rx only, Manufactured by: Julibant Life Sciences Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmace
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0205-2017·2016-12-21

    Jubilant Cadista Recalls Methylprednisolone Tablets Due to Incorrect Expiration Date Labeling

    Jubilant Cadista Pharmaceuticals is recalling 1,512 bottles of Methylprednisolone Tablets, USP, 16 mg, because the expiration date is printed incorrectly as 02/0218 instead of 02/2018.

    Product
    Methylprednisolone Tablets, USP, 16 mg, 50-count bottles, Rx only, Manufactured by Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-003-14.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1500-2014·2014-08-06

    Jubilant Cadista Recalls Losartan Potassium and Hydrochlorothiazide Tablets

    Jubilant Cadista Pharmaceuticals is recalling Losartan Potassium and Hydrochlorothiazide tablets due to the presence of stainless steel blemishes.

    Product
    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-296-2013·2013-05-08

    Jubilant Cadista Recalls Pantoprazole Sodium Tablets Due to Manufacturing Deviations

    Jubilant Cadista Pharmaceuticals is recalling specific lots of Pantoprazole Sodium Delayed Release Tablets because they were not manufactured in accordance with Good Manufacturing Practices.

    Product
    Pantoprazole Sodium Delayed Release Tablets USP, 40 mg, 90 count bottles, Manufactured by Jubilant Life Sciences Ltd, Roorkee-247661 India ;Marketed by Jubilant Cadista Pharmaceuatical Inc Salisbury, MD 21801 NDC 59746-284-90
    Category
    Drug
    Distribution
    Distributed nationwide